missing translation for 'onlineSavingsMsg'
Learn More

STEMCELL Technologies EasySep™ Direct Human B-CLL Cell Isolation Kit

Product Code. 17117951
Encompass
Click to view available options
:
100 mL whole blood
This item is not returnable. View return policy

Product Code. 17117951

Brand: STEMCELL Technologies 19664

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Immunomagnetic isolation of B-CLL cells directly from whole blood

  • This kit isolates untouched and highly purified B-CLL cells directly from human whole blood by fully immunomagnetic negative selection
  • The depletion cocktail in this kit does not contain antibodies against CD43, which can be expressed on malignant cells in chronic lymphocytic leukemia (CLL) samples
  • This cell isolation kit targets non-B cells for removal based on specific surface antigens
  • Unwanted cells are labeled with antibodies and EasySep™ Direct RapidSpheres™, and separated using an EasySep™ magnet
  • Desired cells are simply collected into a new tube and can immediately be used in downstream applications such as nucleic acid extraction, flow cytometry or culture

Specifications

Cell Type B Cells
For Use With (Application) Cell Isolation
Quantity 100 mL whole blood
Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.